Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

297
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
297
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

4.0K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.8K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.8K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

524
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
524
Translation01:31

Translation

143.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No evidence for direct physical interaction of 5-HT <sub>2A</sub> -mGluR2 receptors <i>in vitro</i> or <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026
Same author

Stability-Based Proteomic Methods Add Value to Activity-Based Protein Profiling Studies.

ACS chemical biology·2026
Same author

Structural basis of fungal β-1,3-glucan synthase inhibition by caspofungin.

Nature·2026
Same author

Cryo-EM Structures of Brain-Derived G Protein-Coupled Receptors: The First Direct Visualization from Mammalian Brain Tissue.

bioRxiv : the preprint server for biology·2026
Same author

Identification of 4,5,6,7-Tetrabromo-1<i>H</i>-benzotriazole (TBB) as a Small Molecule MESH1 Inhibitor that Suppresses Ferroptosis.

bioRxiv : the preprint server for biology·2026
Same author

REV1 Loss Triggers a G2/M Cell-Cycle Arrest Through Dysregulation of Mitotic Regulators.

Genes·2026

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

831

Methotrexate recognition by the human reduced folate carrier SLC19A1.

Nicholas J Wright1, Justin G Fedor1, Han Zhang2

  • 1Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA.

Nature
|September 7, 2022
PubMed
Summary

The human reduced folate carrier (hRFC) imports essential folates and chemotherapy drugs. New structures reveal how hRFC recognizes and transports these vital molecules, impacting drug sensitivity.

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.7K

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

831
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.7K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Folates are essential nutrients crucial for cell division and amino acid metabolism.
  • Mammals require extracellular folate uptake, primarily via the human reduced folate carrier (hRFC/SLC19A1).
  • hRFC imports folates and antifolate drugs like methotrexate, influencing chemotherapy effectiveness.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying substrate specificity in hRFC.
  • To understand how hRFC distinguishes between different folate and antifolate molecules.
  • To investigate the structural basis of anion recognition by hRFC.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) to determine hRFC structures.
  • Molecular dynamics (MD) simulations to analyze transport mechanisms.
  • Functional experiments to validate structural findings.

Main Results:

  • Presented high-resolution cryo-EM structures of hRFC in apo and methotrexate-bound states.
  • Identified key structural determinants governing hRFC's substrate selectivity.
  • Elucidated the mechanism of anion recognition and transport by hRFC.

Conclusions:

  • The study provides unprecedented structural insights into hRFC function.
  • Understanding hRFC selectivity is crucial for optimizing antifolate-based therapies.
  • This work lays the foundation for future drug development targeting folate transport.